3 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients ALX-009, OSCN-, bLF - Cystic Fibrosis, Bronchiectasis | Phase 1 | Terminated | Alaxia SAS | 92 | 2015-11-01 | 2022-02-03 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects GSK2793660 solution, GSK2793660 capsule, Placebo solution - Bronchiectasis | Phase 1 | Terminated | GlaxoSmithKline | 33 | 2014-01-28 | 2018-09-13 |
| Study of the Effect of FLUTTERĀ® VRP1 (PEP and Oscillating High Frequency). control group, Flutter group, PEP group - Bronchiectasis | Phase 1 | Terminated | University of Sao Paulo | 30 | 2007-07-01 | 2012-06-28 |
Cystic Fibrosis (1)
Bronchial Diseases (3) · Respiratory Tract Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Genetic Diseases, Inborn (1) · Infant, Newborn, Diseases (1) · Lung Diseases (1) · Pancreatic Diseases (1)
Control Groups (1) · GSK-2793660 (1) · Population Groups (1) · Therapeutics (1) · hypothiocyanite ion (1)
Alaxia SAS (1) · GlaxoSmithKline (1) · University of Sao Paulo (1)
Brazil (1) · France (1) · United Kingdom (1)
Ada C. Gastaldi, doctor (1) · Isabelle Durieu, Prof., MD (1)
PMID 11978924, PMID 1280928, PMID 28733314, PMID 28800383, PMID 9674466
2014 (1)